On 30 July 2014, Pfizer Inc. and Baxter International Inc. announced that
they had entered into an agreement for Pfizer to acquire Baxter's
portfolio of marketed vaccines and related production facilities. We are
pleased to share with you that, effective December 1st, 2014, Pfizer and
Baxter have completed the acquisition.